Parametric Portfolio Associates’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $28K | Sell |
24,475
-110,449
| -82% | -$126K | ﹤0.01% | 3654 |
|
|
2021
Q4 | $337K | Buy |
134,924
+69,471
| +106% | +$174K | ﹤0.01% | 3236 |
|
|
2021
Q3 | $335K | Buy |
65,453
+7,831
| +14% | +$40.1K | ﹤0.01% | 3258 |
|
|
2021
Q2 | $479K | Buy |
57,622
+18,332
| +47% | +$152K | ﹤0.01% | 3101 |
|
|
2021
Q1 | $342K | Buy |
39,290
+15,678
| +66% | +$136K | ﹤0.01% | 3668 |
|
|
2020
Q4 | $256K | Buy |
23,612
+5,394
| +30% | +$58.5K | ﹤0.01% | 3672 |
|
|
2020
Q3 | $217K | Sell |
18,218
-31,831
| -64% | -$379K | ﹤0.01% | 3624 |
|
|
2020
Q2 | $804K | Sell |
50,049
-21,674
| -30% | -$348K | ﹤0.01% | 3037 |
|
|
2020
Q1 | $1.11M | Sell |
71,723
-1,100
| -2% | -$17.1K | ﹤0.01% | 2746 |
|
|
2019
Q4 | $1.79M | Buy |
+72,823
| New | +$1.79M | ﹤0.01% | 2760 |
|